ResearchMoz

Pharmaceutical Market Research Reports & Industry Analysis

Our coverage in Pharmaceuticals Industry includes large MNC pharmaceutical companies, mid-sized & specialty pharmaceutical companies, off patent or generic drug manufacturers, biotechnology and life sciences companies, contract research companies. We also cover regulatory guidance, contract sales, manufacturing technologies and raw materials in the pharmaceuticals space.

The extensive research & analysis provides us with insight that is a valuable resource for decision-making in this highly vital sector. Our approach and methodology is will enable you a quick and effective understand the key insights of Pharmaceuticals Industry, thus enabling you to respond as market evolves.

Pharmaceutical

Browse reports in Pharmaceutical

Displaying 451 to 480 (of 3140 records)
Pages: « Prev  11 12 13 14 15 16 17 18 19 20   Next »
Primitive Neuroectodermal Tumor (PNET) - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Primitive Neuroectodermal Tumor (PNET) - Pipeline Review, H2 2012 Summary Global Markets Directs, 'Primitive Neuroectodermal Tumor (PNET) - Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Primitive Neuroectodermal Tumor (PNET), complete with latest updates, and special features on...
$2000
Osteopenia - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Osteopenia Pipeline Review, H2 2012 Global Markets Directs, 'Osteopenia Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Osteopenia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Gastric Ulcers - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Gastric Ulcers Pipeline Review, H2 2012 Global Markets Directs, 'Gastric Ulcers Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Gastric Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in...
$2000
Other Metabolic Disorders - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Other Metabolic Disorders Pipeline Review, H2 2012 Global Markets Directs, 'Other Metabolic disorders Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Other Metabolic disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Pompe Disease - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Pompe Disease Pipeline Review, H2 2012 Global Markets Directs, 'Pompe Disease Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Pompe Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Pre-Diabetes/Impaired Glucose Tolerance - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Pre-Diabetes/Impaired Glucose Tolerance Pipeline Review, H2 2012 Global Markets Directs, 'Pre-Diabetes/Impaired Glucose Tolerance Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Pre-Diabetes/Impaired Glucose Tolerance, complete with latest updates, and special features on...
$2000
Japanese Encephalitis - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Japanese Encephalitis Pipeline Review, H2 2012 Global Markets Directs, 'Japanese Encephalitis Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Japanese Encephalitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Hepatitis D - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Hepatitis D Pipeline Review, H2 2012 Global Markets Directs, 'Hepatitis D Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Hepatitis D, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Gastrointestinal Bleeding - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Gastrointestinal Bleeding - Pipeline Review, H2 2012 Summary Global Markets Directs, 'Gastrointestinal Bleeding - Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Gastrointestinal Bleeding, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
Hepatorenal Syndrome - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Hepatorenal Syndrome Pipeline Review, H2 2012 Global Markets Directs, 'Hepatorenal Syndrome Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Hepatorenal Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Spinocerebellar Ataxias - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Spinocerebellar Ataxias Pipeline Review, H2 2012 Global Markets Directs, 'Spinocerebellar Ataxias Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Spinocerebellar Ataxias, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Obstructive Sleep Apnea - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Obstructive Sleep Apnea Pipeline Review, H2 2012 Global Markets Directs, 'Obstructive Sleep Apnea Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Obstructive Sleep Apnea, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Pipeline Review, H2 2012 Global Markets Directs, 'Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ), complete with latest...
$2000
Postoperative Ileus - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Postoperative Ileus Pipeline Review, H2 2012 Global Markets Directs, 'Postoperative Ileus Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Postoperative Ileus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Traveler's Diarrhea - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Traveler's Diarrhea Pipeline Review, H2 2012 Global Markets Directs, 'Traveler's Diarrhea Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Traveler's Diarrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Rhinovirus Infection - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Rhinovirus Infection Pipeline Review, H2 2012 Global Markets Directs, 'Rhinovirus Infection Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Rhinovirus Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Neonatal Respiratory Distress Syndrome - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Neonatal Respiratory Distress Syndrome Pipeline Review, H2 2012 Global Markets Directs, 'Neonatal Respiratory Distress Syndrome Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Neonatal Respiratory Distress Syndrome, complete with latest updates, and special features on...
$2000
Community Acquired Bacterial Pneumonia - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Community Acquired Bacterial Pneumonia Pipeline Review, H2 2012 Global Markets Directs, 'Community Acquired Bacterial Pneumonia Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Community Acquired Bacterial Pneumonia, complete with latest updates, and special features on...
$2000
Bacterial Conjunctivitis - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Bacterial Conjunctivitis Pipeline Review, H2 2012 Global Markets Directs, 'Bacterial Conjunctivitis Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bacterial Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Corneal Neovascularization - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Corneal Neovascularization Pipeline Review, H2 2012 Global Markets Directs, 'Corneal Neovascularization Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Corneal Neovascularization, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
Central Retinal Vein Occlusion - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Central Retinal Vein Occlusion Pipeline Review, H2 2012 Global Markets Directs, 'Central Retinal Vein Occlusion Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Central Retinal Vein Occlusion, complete with latest updates, and special features on late-stage and discontinued...
$2000
Vasomotor Symptoms of Menopause - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Vasomotor Symptoms of Menopause - Pipeline Review, H2 2012 Summary Global Markets Directs, 'Vasomotor Symptoms of Menopause - Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Vasomotor Symptoms of Menopause, complete with latest updates, and special features on late-stage and...
$2000
General Anxiety Disorder - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
General Anxiety Disorder Pipeline Review, H2 2012 Global Markets Directs, 'General Anxiety Disorder Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for General Anxiety Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Adenovirus Infections - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Adenovirus Infections Pipeline Review, H2 2012 Global Markets Directs, 'Adenovirus Infections Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Adenovirus Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Cancer Anorexia - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Cancer Anorexia Pipeline Review, H2 2012 Global Markets Directs, 'Cancer Anorexia Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Cancer Anorexia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved...
$2000
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Chemotherapy Induced Peripheral Neuropathy Pipeline Review, H2 2012 Global Markets Directs, 'Chemotherapy Induced Peripheral Neuropathy Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Induced Peripheral Neuropathy, complete with latest updates, and special...
$2000
Microalbuminuria - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Microalbuminuria Pipeline Review, H2 2012 Global Markets Directs, 'Microalbuminuria Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Microalbuminuria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Malignant Pleural Effusion - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Malignant Pleural Effusion Pipeline Review, H2 2012 Global Markets Directs, 'Malignant Pleural Effusion Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Malignant Pleural Effusion, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
Cellulitis - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Cellulitis Pipeline Review, H2 2012 Global Markets Directs, 'Cellulitis Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Cellulitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Dyspnea - Pipeline Review, H2 2012
Dec 2012   |   By - Global Markets Direct
Dyspnea Pipeline Review, H2 2012 Global Markets Directs, 'Dyspnea Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Dyspnea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic...
$2000
 
Displaying 451 to 480 (of 3140 records)
Pages: « Prev  11 12 13 14 15 16 17 18 19 20   Next »